Disease modifying drug therapy
Published May 2009
Contents
- Introduction
- What are disease modifying drugs and what do they do?
- What are disease modifying drugs?
- How the drugs work
- Eligibility criteria
- What to expect from disease modifying drugs
- Self-administered drugs
- Hospital-administered drug
- Switching and discontinuing
- Other drugs used in MS other
- Further sources of information and support
Acknowledgments
We would like to thank the people with MS who reviewed this book, as well as representatives from each of the pharmaceutical manufacturers and the following specialist nurses: Samantha Colhoun, University Hospital Birmingham, West Midlands, Nikki Embrey, North Staffordshire University Hospital, Stoke-on-Trent, Gail Hayes, Mardon Neuro-Rehabilitation Centre, Exeter, Alan Izat, Douglas Grant Rehabilitation Centre, Scotland; Andrew Jones, Royal Alexandra Hospital, Denbighshire, Wales; Deborah Macmillan, Darent Valley Hospital, Kent, Heidi Thompson, Craigavon Area Hospital, Northern Ireland; Bronwyn Roper, Norfolk and Norwich University Hospital, Norwich.